6622 — Zhaoke Ophthalmology Share Price
0.000.00%
Last trade - 00:00- HK$737.29m
- -HK$579.02m
- CNY18.75m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.35 | ||
| Price to Tang. Book | 0.43 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 38.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -18.07% | ||
| Return on Equity | -17.51% | ||
| Operating Margin | -2008.36% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | n/a | n/a | n/a | 18.75 | 125.08 | 150.38 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zhaoke Ophthalmology Ltd is a China-based investment holding company principally engaged in the development, manufacturing and marketing of ophthalmic drugs. The Company’s products include innovative drugs and generic drugs. The Company ‘s products are mainly applied in five ophthalmic indications, including dry eye disease (DED), wet age-related macular degeneration (wAMD), diabetic macular edema (DME), myopia and glaucoma.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 29th, 2020
- Public Since
- April 29th, 2021
- No. of Employees
- 313
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 546,139,172
- Address
- No. 1 Meide 3rd Road, Pearl River, GUANGZHOU
- Web
- https://www.zkoph.com/
- Phone
- +86 2039062888
- Auditors
- KPMG
Upcoming Events for 6622
Similar to 6622
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Zhaoke Ophthalmology share price?
As of Today at 12:18 UTC, shares in Zhaoke Ophthalmology are trading at HK$1.41. This share price information is delayed by 15 minutes.
How has the Zhaoke Ophthalmology share price performed this year?
Shares in Zhaoke Ophthalmology last closed at HK$1.41 and the price had moved by -60.39% over the past 365 days. In terms of relative price strength the Zhaoke Ophthalmology share price has underperformed the FTSE Developed Asia Pacific Index by -62.1% over the past year.
What are the analyst and broker recommendations for Zhaoke Ophthalmology?
The overall consensus recommendation for Zhaoke Ophthalmology is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Zhaoke Ophthalmology dividend yield?
Zhaoke Ophthalmology does not currently pay a dividend.
Does Zhaoke Ophthalmology pay a dividend?
Zhaoke Ophthalmology does not currently pay a dividend.
When does Zhaoke Ophthalmology next pay dividends?
Zhaoke Ophthalmology does not currently pay a dividend.
How do I buy Zhaoke Ophthalmology shares?
To buy shares in Zhaoke Ophthalmology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zhaoke Ophthalmology?
As of the previous close price of HK$1.41, shares in Zhaoke Ophthalmology had a market capitalisation of HK$770.06m.
Where are Zhaoke Ophthalmology shares listed?
Here are the trading details for Zhaoke Ophthalmology:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6622
What kind of share is Zhaoke Ophthalmology?
Based on an overall assessment of its quality, value and momentum Zhaoke Ophthalmology is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zhaoke Ophthalmology share price forecast for 2024?
The analyst consensus target price for shares in Zhaoke Ophthalmology is HK$7.72. That is 447.36% above the last closing price of HK$1.41.
Analysts covering Zhaoke Ophthalmology currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.73 for the next financial year.
What is the trend in the Zhaoke Ophthalmology share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zhaoke Ophthalmology. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -64%.
As of the last closing price of HK$1.41, shares in Zhaoke Ophthalmology were trading -47.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zhaoke Ophthalmology PE Ratio?
The Zhaoke Ophthalmology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zhaoke Ophthalmology?
We do not have data on Zhaoke Ophthalmology's directors